A mutation in PIK3CD gene causing pediatric systemic lupus erythematosus
Identifieur interne : 000318 ( Pmc/Corpus ); précédent : 000317; suivant : 000319A mutation in PIK3CD gene causing pediatric systemic lupus erythematosus
Auteurs : Guo-Min Li ; Hai-Mei Liu ; Wan-Zhen Guan ; Hong Xu ; Bing-Bing Wu ; Jia-Yan Feng ; Li SunSource :
- Medicine [ 0025-7974 ] ; 2019.
Abstract
Gain of function (GOF) mutations in
We report a patient who was diagnosed with systemic lupus erythematosus (SLE) at a young age and was recently found to carry heterozygous mutations in
Activated PI3Kδ syndrome.
Oral prednisolone and hydroxychloroquine combined with mycophenolate mofetil was given to the patient. He was currently receiving intravenous immunoglobulin per month in association with hydroxychloroquine, low-dose prednisolone, and mycophenolate mofetil.
At present, the level of complement restored to normal, hematuria and proteinuria disappeared, and liver function returned to normal.
SLE may be a novel phenotype of GOF mutation in
Url:
DOI: 10.1097/MD.0000000000015329
PubMed: 31045771
PubMed Central: 6504300
Links to Exploration step
PMC:6504300Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A mutation in <italic>PIK3CD</italic> gene causing pediatric systemic lupus erythematosus</title><author><name sortKey="Li, Guo Min" sort="Li, Guo Min" uniqKey="Li G" first="Guo-Min" last="Li">Guo-Min Li</name><affiliation><nlm:aff id="aff1">Department of Rheumatology</nlm:aff></affiliation></author><author><name sortKey="Liu, Hai Mei" sort="Liu, Hai Mei" uniqKey="Liu H" first="Hai-Mei" last="Liu">Hai-Mei Liu</name><affiliation><nlm:aff id="aff1">Department of Rheumatology</nlm:aff></affiliation></author><author><name sortKey="Guan, Wan Zhen" sort="Guan, Wan Zhen" uniqKey="Guan W" first="Wan-Zhen" last="Guan">Wan-Zhen Guan</name><affiliation><nlm:aff id="aff1">Department of Rheumatology</nlm:aff></affiliation></author><author><name sortKey="Xu, Hong" sort="Xu, Hong" uniqKey="Xu H" first="Hong" last="Xu">Hong Xu</name><affiliation><nlm:aff id="aff1">Department of Rheumatology</nlm:aff></affiliation></author><author><name sortKey="Wu, Bing Bing" sort="Wu, Bing Bing" uniqKey="Wu B" first="Bing-Bing" last="Wu">Bing-Bing Wu</name><affiliation><nlm:aff id="aff2">Medical Transformation Centre</nlm:aff></affiliation></author><author><name sortKey="Feng, Jia Yan" sort="Feng, Jia Yan" uniqKey="Feng J" first="Jia-Yan" last="Feng">Jia-Yan Feng</name><affiliation><nlm:aff id="aff3">Department of Pathology, Children's Hospital of Fudan University, Shanghai, China.</nlm:aff></affiliation></author><author><name sortKey="Sun, Li" sort="Sun, Li" uniqKey="Sun L" first="Li" last="Sun">Li Sun</name><affiliation><nlm:aff id="aff1">Department of Rheumatology</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">31045771</idno><idno type="pmc">6504300</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504300</idno><idno type="RBID">PMC:6504300</idno><idno type="doi">10.1097/MD.0000000000015329</idno><date when="2019">2019</date><idno type="wicri:Area/Pmc/Corpus">000318</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000318</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">A mutation in <italic>PIK3CD</italic> gene causing pediatric systemic lupus erythematosus</title><author><name sortKey="Li, Guo Min" sort="Li, Guo Min" uniqKey="Li G" first="Guo-Min" last="Li">Guo-Min Li</name><affiliation><nlm:aff id="aff1">Department of Rheumatology</nlm:aff></affiliation></author><author><name sortKey="Liu, Hai Mei" sort="Liu, Hai Mei" uniqKey="Liu H" first="Hai-Mei" last="Liu">Hai-Mei Liu</name><affiliation><nlm:aff id="aff1">Department of Rheumatology</nlm:aff></affiliation></author><author><name sortKey="Guan, Wan Zhen" sort="Guan, Wan Zhen" uniqKey="Guan W" first="Wan-Zhen" last="Guan">Wan-Zhen Guan</name><affiliation><nlm:aff id="aff1">Department of Rheumatology</nlm:aff></affiliation></author><author><name sortKey="Xu, Hong" sort="Xu, Hong" uniqKey="Xu H" first="Hong" last="Xu">Hong Xu</name><affiliation><nlm:aff id="aff1">Department of Rheumatology</nlm:aff></affiliation></author><author><name sortKey="Wu, Bing Bing" sort="Wu, Bing Bing" uniqKey="Wu B" first="Bing-Bing" last="Wu">Bing-Bing Wu</name><affiliation><nlm:aff id="aff2">Medical Transformation Centre</nlm:aff></affiliation></author><author><name sortKey="Feng, Jia Yan" sort="Feng, Jia Yan" uniqKey="Feng J" first="Jia-Yan" last="Feng">Jia-Yan Feng</name><affiliation><nlm:aff id="aff3">Department of Pathology, Children's Hospital of Fudan University, Shanghai, China.</nlm:aff></affiliation></author><author><name sortKey="Sun, Li" sort="Sun, Li" uniqKey="Sun L" first="Li" last="Sun">Li Sun</name><affiliation><nlm:aff id="aff1">Department of Rheumatology</nlm:aff></affiliation></author></analytic><series><title level="j">Medicine</title><idno type="ISSN">0025-7974</idno><idno type="eISSN">1536-5964</idno><imprint><date when="2019">2019</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><title>Abstract</title><sec><title>Rationale:</title><p>Gain of function (GOF) mutations in <italic>PIK3CD</italic> gene encoding PI3K p110δ were recently associated with a novel combined immune deficiency characterized by recurrent sinopulmonary infections, CD<sub>4</sub><sup>+</sup> lymphopenia, reduced class-switched memory B cells, lymphadenopathy, cytomegalovirus and/or epstein-Barr virus (EBV) viremia, and EBV-related lymphoma. A subset of affected patients also had elevated serum IgM.</p></sec><sec><title>Patient concerns:</title><p>We report a patient who was diagnosed with systemic lupus erythematosus (SLE) at a young age and was recently found to carry heterozygous mutations in <italic>PIK3CD</italic>. The patient not only presented with recurrent sinopulmonary infections, CD<sub>4</sub><sup>+</sup> lymphopenia, lymphadenopathy, EBV viremia, and elevated serum IgM, but also met classification criteria of SLE based on persistent proteinuria and hematuria, leukopenia and anemia, low level of serum complement, and positive autoantibody for antinuclear antibodies.</p></sec><sec><title>Diagnoses:</title><p>Activated PI3Kδ syndrome.</p></sec><sec><title>Interventions:</title><p>Oral prednisolone and hydroxychloroquine combined with mycophenolate mofetil was given to the patient. He was currently receiving intravenous immunoglobulin per month in association with hydroxychloroquine, low-dose prednisolone, and mycophenolate mofetil.</p></sec><sec><title>Outcomes:</title><p>At present, the level of complement restored to normal, hematuria and proteinuria disappeared, and liver function returned to normal.</p></sec><sec><title>Lessons:</title><p>SLE may be a novel phenotype of GOF mutation in <italic>PI3CKD</italic> gene (GOF PIK3CD).</p></sec></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Jean, S" uniqKey="Jean S">S Jean</name></author><author><name sortKey="Kiger, Aa" uniqKey="Kiger A">AA Kiger</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Fruman, Da" uniqKey="Fruman D">DA Fruman</name></author><author><name sortKey="Rommel, C" uniqKey="Rommel C">C Rommel</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chiu, H" uniqKey="Chiu H">H Chiu</name></author><author><name sortKey="Mallya, S" uniqKey="Mallya S">S Mallya</name></author><author><name sortKey="Nguyen, P" uniqKey="Nguyen P">P Nguyen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Deau, Mc" uniqKey="Deau M">MC Deau</name></author><author><name sortKey="Heurtier, L" uniqKey="Heurtier L">L Heurtier</name></author><author><name sortKey="Frange, P" uniqKey="Frange P">P Frange</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Elgizouli, M" uniqKey="Elgizouli M">M Elgizouli</name></author><author><name sortKey="Lowe, Dm" uniqKey="Lowe D">DM Lowe</name></author><author><name sortKey="Speckmann, C" uniqKey="Speckmann C">C Speckmann</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Coulter, Ti" uniqKey="Coulter T">TI Coulter</name></author><author><name sortKey="Chandra, A" uniqKey="Chandra A">A Chandra</name></author><author><name sortKey="Bacon, Cm" uniqKey="Bacon C">CM Bacon</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Michalovich, D" uniqKey="Michalovich D">D Michalovich</name></author><author><name sortKey="Nejentsev, S" uniqKey="Nejentsev S">S Nejentsev</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Picard, C" uniqKey="Picard C">C Picard</name></author><author><name sortKey="Bobby Gaspar, H" uniqKey="Bobby Gaspar H">H Bobby Gaspar</name></author><author><name sortKey="Al Herz, W" uniqKey="Al Herz W">W Al-Herz</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bousfha, A" uniqKey="Bousfha A">A Bousfha</name></author><author><name sortKey="Jeddane, L" uniqKey="Jeddane L">L Jeddane</name></author><author><name sortKey="Picard, C" uniqKey="Picard C">C Picard</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Xiao, X" uniqKey="Xiao X">X Xiao</name></author><author><name sortKey="Miao, Q" uniqKey="Miao Q">Q Miao</name></author><author><name sortKey="Chang, C" uniqKey="Chang C">C Chang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Rahiminejad, Ms" uniqKey="Rahiminejad M">MS Rahiminejad</name></author><author><name sortKey="Mirmohammad Sadeghi, M" uniqKey="Mirmohammad Sadeghi M">M Mirmohammad Sadeghi</name></author><author><name sortKey="Mohammadinejad, P" uniqKey="Mohammadinejad P">P Mohammadinejad</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Abolhassani, H" uniqKey="Abolhassani H">H Abolhassani</name></author><author><name sortKey="Gharib, B" uniqKey="Gharib B">B Gharib</name></author><author><name sortKey="Shahinpour, S" uniqKey="Shahinpour S">S Shahinpour</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Cunningham Rundles, C" uniqKey="Cunningham Rundles C">C Cunningham-Rundles</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Abolhassani, H" uniqKey="Abolhassani H">H Abolhassani</name></author><author><name sortKey="Amirkashani, D" uniqKey="Amirkashani D">D Amirkashani</name></author><author><name sortKey="Parvaneh, N" uniqKey="Parvaneh N">N Parvaneh</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Patiroglu, T" uniqKey="Patiroglu T">T Patiroglu</name></author><author><name sortKey="Gungor, He" uniqKey="Gungor H">HE Gungor</name></author><author><name sortKey="Unal, E" uniqKey="Unal E">E Unal</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Fried, Aj" uniqKey="Fried A">AJ Fried</name></author><author><name sortKey="Bonilla, Fa" uniqKey="Bonilla F">FA Bonilla</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Glocker, E" uniqKey="Glocker E">E Glocker</name></author><author><name sortKey="Grimbacher, B" uniqKey="Grimbacher B">B Grimbacher</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lavrador, V" uniqKey="Lavrador V">V Lavrador</name></author><author><name sortKey="Correia, F" uniqKey="Correia F">F Correia</name></author><author><name sortKey="Sampaio, R" uniqKey="Sampaio R">R Sampaio</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Cunningham Rundles, C" uniqKey="Cunningham Rundles C">C Cunningham-Rundles</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Angulo, I" uniqKey="Angulo I">I Angulo</name></author><author><name sortKey="Vadas, O" uniqKey="Vadas O">O Vadas</name></author><author><name sortKey="Garcon, F" uniqKey="Garcon F">F Garçon</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Takeda, Aj" uniqKey="Takeda A">AJ Takeda</name></author><author><name sortKey="Zhang, Y" uniqKey="Zhang Y">Y Zhang</name></author><author><name sortKey="Dornan, Gl" uniqKey="Dornan G">GL Dornan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Arjunaraja, S" uniqKey="Arjunaraja S">S Arjunaraja</name></author><author><name sortKey="Snow, Al" uniqKey="Snow A">AL Snow</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Suarez Fueyo, A" uniqKey="Suarez Fueyo A">A Suárez-Fueyo</name></author><author><name sortKey="Barber, Df" uniqKey="Barber D">DF Barber</name></author><author><name sortKey="Martinez Ara, J" uniqKey="Martinez Ara J">J Martínez-Ara</name></author></analytic></biblStruct></listBibl></div1></back></TEI><pmc article-type="case-report"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id><journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id><journal-id journal-id-type="publisher-id">MEDI</journal-id><journal-title-group><journal-title>Medicine</journal-title></journal-title-group><issn pub-type="ppub">0025-7974</issn><issn pub-type="epub">1536-5964</issn><publisher><publisher-name>Wolters Kluwer Health</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31045771</article-id><article-id pub-id-type="pmc">6504300</article-id><article-id pub-id-type="publisher-id">MD-D-18-09387</article-id><article-id pub-id-type="doi">10.1097/MD.0000000000015329</article-id><article-id pub-id-type="art-access-id">15329</article-id><article-categories><subj-group subj-group-type="hwp-journal-coll"><subject>3500</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Clinical Case Report</subject></subj-group></article-categories><title-group><article-title>A mutation in <italic>PIK3CD</italic> gene causing pediatric systemic lupus erythematosus</article-title><subtitle>A case report</subtitle></title-group><contrib-group><contrib contrib-type="author"><name><surname>Li</surname><given-names>Guo-Min</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Hai-Mei</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Guan</surname><given-names>Wan-Zhen</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Hong</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Bing-Bing</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Feng</surname><given-names>Jia-Yan</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sun</surname><given-names>Li</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref rid="cor1" ref-type="corresp"><sup>∗</sup></xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>NA.</surname><given-names></given-names></name></contrib></contrib-group><aff id="aff1"><label>a</label>Department of Rheumatology</aff><aff id="aff2"><label>b</label>Medical Transformation Centre</aff><aff id="aff3"><label>c</label>Department of Pathology, Children's Hospital of Fudan University, Shanghai, China.</aff><author-notes id="cor1"><corresp><label>∗</label>Correspondence: Li Sun, Department of Rheumatology, Children's Hospital of Fudan University, Shanghai, China (e-mail: <email>lillysun@263.net</email>).</corresp></author-notes><pub-date pub-type="collection"><month>5</month><year>2019</year></pub-date><pub-date pub-type="epub"><day>03</day><month>5</month><year>2019</year></pub-date><volume>98</volume><issue>18</issue><elocation-id>e15329</elocation-id><history><date date-type="received"><day>18</day><month>12</month><year>2018</year></date><date date-type="rev-recd"><day>17</day><month>3</month><year>2019</year></date><date date-type="accepted"><day>25</day><month>3</month><year>2019</year></date></history><permissions><copyright-statement>Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0">http://creativecommons.org/licenses/by-nc/4.0</ext-link></license-p></license></permissions><self-uri xlink:type="simple" xlink:href="medi-98-e15329.pdf"></self-uri><abstract><title>Abstract</title><sec><title>Rationale:</title><p>Gain of function (GOF) mutations in <italic>PIK3CD</italic> gene encoding PI3K p110δ were recently associated with a novel combined immune deficiency characterized by recurrent sinopulmonary infections, CD<sub>4</sub><sup>+</sup> lymphopenia, reduced class-switched memory B cells, lymphadenopathy, cytomegalovirus and/or epstein-Barr virus (EBV) viremia, and EBV-related lymphoma. A subset of affected patients also had elevated serum IgM.</p></sec><sec><title>Patient concerns:</title><p>We report a patient who was diagnosed with systemic lupus erythematosus (SLE) at a young age and was recently found to carry heterozygous mutations in <italic>PIK3CD</italic>. The patient not only presented with recurrent sinopulmonary infections, CD<sub>4</sub><sup>+</sup> lymphopenia, lymphadenopathy, EBV viremia, and elevated serum IgM, but also met classification criteria of SLE based on persistent proteinuria and hematuria, leukopenia and anemia, low level of serum complement, and positive autoantibody for antinuclear antibodies.</p></sec><sec><title>Diagnoses:</title><p>Activated PI3Kδ syndrome.</p></sec><sec><title>Interventions:</title><p>Oral prednisolone and hydroxychloroquine combined with mycophenolate mofetil was given to the patient. He was currently receiving intravenous immunoglobulin per month in association with hydroxychloroquine, low-dose prednisolone, and mycophenolate mofetil.</p></sec><sec><title>Outcomes:</title><p>At present, the level of complement restored to normal, hematuria and proteinuria disappeared, and liver function returned to normal.</p></sec><sec><title>Lessons:</title><p>SLE may be a novel phenotype of GOF mutation in <italic>PI3CKD</italic> gene (GOF PIK3CD).</p></sec></abstract><kwd-group><title>Keywords</title><kwd><italic>PI3CKD</italic> gene</kwd><kwd>primary immunodeficiency</kwd><kwd>systemic lupus erythematosus</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec><label>1</label><title>Introduction</title><p>Human cells express three classes of phosphoinositide 3-kinase (PI3K) (I, II, and III).<sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup> There are three class IA PI3Ks in mammalian cells, α, β, and δ, that catalyze the phosphorylation of PtdIns (4,5)P2 to generate PtdIns (3,4,5)P3 (PIP3).<sup>[<xref rid="R2" ref-type="bibr">2</xref>]</sup> Each class IA PI3K is composed of a catalytic subunit, p110α, p110β, or p110δ (encoded by genes <italic>PIK3CA</italic>, <italic>PIK3CB</italic>, and <italic>PIK3CD</italic>, respectively), and one of the five regulatory subunits: p85α, p55α, p50α (all encoded by different transcripts of the <italic>PIK3R1</italic> gene), p85β (encoded by the <italic>PIK3R2</italic> gene), or p55γ (encoded by the <italic>PIK3R3</italic> gene).<sup>[<xref rid="R3" ref-type="bibr">3</xref>]</sup> Gain of function (GOF) PIK3CD and PIK3R1 that cause a combined immunodeficiency syndrome referred to as activated PI3Kδ syndrome (APDS) or p110δ-activating mutation causing senescent T cells, lymphadenopathy and immunodeficiency (PASLI).<sup>[<xref rid="R4" ref-type="bibr">4</xref>–<xref rid="R6" ref-type="bibr">6</xref>]</sup> APDS is characterized by recurrent sinopulmonary infections with associated lung damage, lymphadenopathy, reduced class-switched memory B cells, epstein-Barr virus (EBV) and cytomegalovirus viremia, as well as EBV and non-EBV-driven malignancies.<sup>[<xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R7" ref-type="bibr">7</xref>]</sup> We describe a child with GOF PIK3CD. The child not only presented with recurrent sinopulmonary infections, CD<sub>4</sub><sup>+</sup> lymphopenia, lymphadenopathy, EBV viremia, and elevated serum IgM, but also met classification criteria of systemic lupus erythematosus (SLE) based on persistent proteinuria and hematuria, leukopenia and anemia, low level of serum complement, and positive autoantibody for antinuclear antibodies (ANA).</p></sec><sec><label>2</label><title>Case reports</title><p>The patient, a 15-year-old Chinese boy, presented with respiratory tract infections at the age of 9. He was referred to our hospital for evaluation because of recurrent sinopulmonary infections, neck lymphadenopathy, and splenomegaly at the age of 10. Physical examination disclosed short stature (−2.6 standard deviation), neck lymphadenopathy, splenomegaly, and verruca plana all over the body. Other physical findings were unremarkable. Laboratory testing revealed leukopenia, anemia, thrombocytopenia, hematuria, proteinuria, low level of complement and high levels of erythrocyte sedimentation rate, and C-reactive protein. Coombs test was positive. Autoantibody was positive for ANA (1:640) and peripheral anti-neutrophil cytoplasmic antibodies (1:100), and the others are negative. Serum level of complements was low, such as C3, C4, and CH50. Serum level of IgM and IgE was elevated, but IgG and IgA was normal. Lymphocyte subsets by flow cytometry revealed CD<sub>4</sub><sup>+</sup> lymphopenia. Abdominal contrast-enhanced MRI revealed splenomegaly (Fig. <xref ref-type="fig" rid="F1">1</xref>A). Lung CT scan showed partial consolidation of left upper lung with bronchiectasis and left upper bronchial stenosis (Fig. <xref ref-type="fig" rid="F1">1</xref>B and C). The clinical and laboratory data met four criteria of SLE of the Systemic Lupus International Collaborating Clinics (renal and hematological disorder, low level of complement, and positive ANA). Therefore, the patient was diagnosed of SLE, lupus nephritis, and recurrent sinopulmonary infections. Renal biopsy was also done because of persistent hematuria and proteinuria, and it displayed moderately increased mesangial matrix and mesangial hypercellularity under the light microscope; subepithelial deposits was noted, and some mesangial changes may be present as seen in electron microscopy. Immunofluorescence was positive for C1q, C3, IgG, IgM, and Fb (Fig. <xref ref-type="fig" rid="F2">2</xref>). The patient was given oral prednisolone and hydroxychloroquine combined with mycophenolate mofetil. Six months later, the level of complement was restored to normal, hematuria and proteinuria disappeared, and liver function returned to normal. He was currently receiving intravenous immunoglobulin in association with hydroxychloroquine, low-dose prednisolone, and mycophenolate mofetil, with a good efficacy. Family history revealed that his mother died of gastric cancer. Whole exome sequencing was performed in patient and in his father, when he was at the age of 15 and the <italic>PI3KCD</italic> gene was found to exhibit good coverage. Sanger sequencing of <italic>PIK3CD</italic> gene confirmed a known and <italic>de novo</italic> GOF heterozygous mutation c.3061G>A (p.E1021K) in patient (Fig. <xref ref-type="fig" rid="F3">3</xref>). Informed written consent was obtained from the patient's father for publication of this case report and accompanying images. Ethics board approval and consent was obtained for this work from the Ethics Committee at the Children's Hospital of Fudan University, Shanghai, China (ekyy-2015–28).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Imaging features of abdomen and lung in a patient. (A) Abdominal contrast-enhanced CT revealed hepatosplenomegaly. (B) Lung CT scan showed partial consolidation of left upper lung with bronchiectasis and left upper bronchial stenosis (prior treatment). (C) Lung CT scan showed partial consolidation of left upper lung with bronchiectasis and left upper bronchial stenosis (post-treatment).</p></caption><graphic xlink:href="medi-98-e15329-g001"></graphic></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>Renal biopsy showed lupus nephritis type IV under light (×400), electron (×11600), and immunofluorescence (×400) microscopy.</p></caption><graphic xlink:href="medi-98-e15329-g002"></graphic></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p>Mutation analysis in <italic>PIK3CD</italic> gene. P = patient; F = father.</p></caption><graphic xlink:href="medi-98-e15329-g003"></graphic></fig></sec><sec><label>3</label><title>Discussion</title><p>Our patient presented with recurrent sinopulmonary infections, CD<sub>4</sub><sup>+</sup> lymphopenia, lymphadenopathy, EBV viremia, and elevated serum IgM. Lung CT scan showed lung damage, such as partial consolidation of left upper lung with bronchiectasis and left upper bronchial stenosis. WAS and Sanger sequencing both revealed a known GOF heterozygous mutation c3061G>A (p.E1021K) in the patient. The E1021K variant in the C-lobe of the p110δ kinase domain is by far the most frequently reported APDS mutation.<sup>[<xref rid="R7" ref-type="bibr">7</xref>]</sup> Therefore, the patient met diagnosis criteria of APDS, which belongs to primary immunodeficiency. Due to leukopenia, anemia, thrombocytopenia, hematuria, proteinuria, low level of complement, positive Coombs test, and ANA, he also met classification criteria of SLE, which is a prototypic, systemic, autoimmune disease.</p><p>The coexistence of immunodeficiency and autoimmunity appears paradoxical in certain types of primary immunodeficiencies, as one represents a hyperimmune state and the other a hypoimmune state.<sup>[<xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R9" ref-type="bibr">9</xref>]</sup> However, this paradox may not actually be all that implausible due to the complex nature of immune cells, signaling pathways, and their interactions.<sup>[<xref rid="R10" ref-type="bibr">10</xref>]</sup> The most common autoimmune disorders in primary antibody deficiencies are immune thrombocytopenic purpura and autoimmune hemolytic anemia.<sup>[<xref rid="R11" ref-type="bibr">11</xref>]</sup> Moreover, other diseases including autoimmune thyroid disease,<sup>[<xref rid="R12" ref-type="bibr">12</xref>]</sup> type 1 diabetes,<sup>[<xref rid="R13" ref-type="bibr">13</xref>]</sup> rheumatoid arthritis,<sup>[<xref rid="R14" ref-type="bibr">14</xref>]</sup> SLE,<sup>[<xref rid="R15" ref-type="bibr">15</xref>]</sup> dermatomyositis,<sup>[<xref rid="R16" ref-type="bibr">16</xref>]</sup> inflammatory bowel diseases,<sup>[<xref rid="R17" ref-type="bibr">17</xref>]</sup> alopecia areata,<sup>[<xref rid="R15" ref-type="bibr">15</xref>]</sup> vitiligo,<sup>[<xref rid="R12" ref-type="bibr">12</xref>]</sup> and glomerulonephritis<sup>[<xref rid="R18" ref-type="bibr">18</xref>]</sup> are also common in primary antibody deficiencies due to the lack of self-tolerance.<sup>[<xref rid="R19" ref-type="bibr">19</xref>]</sup></p><p>A study, the largest cohort to date, showed that 43% (22/53) of the cohort had clinical features suggestive of autoimmune or inflammatory disease, which included Coombs-positive hemolytic anemia (7), trilineage cytopenia (2), glomerulonephritis (3), exocrine pancreatic insufficiency (3), autoantibody-positive thyroid disease (3), cirrhosis (3), and seronegative arthritis (2).<sup>[<xref rid="R6" ref-type="bibr">6</xref>]</sup> No typically immunological indicators of SLE were found in these patients with autoimmune or inflammatory disease, such as ANA, anti-dsDNA, and low level of complement.<sup>[<xref rid="R6" ref-type="bibr">6</xref>]</sup> A few other studies around the world did not found typically immunological indicators of SLE.<sup>[<xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R21" ref-type="bibr">21</xref>]</sup> Nonetheless, in a genetic model with enhanced activation of class IA PI3K in T cells, mice showed a greater tumor index but died of a lupus-like disease.<sup>[<xref rid="R22" ref-type="bibr">22</xref>]</sup> Interestingly, Suárez-Fueyo et al<sup>[<xref rid="R23" ref-type="bibr">23</xref>]</sup> found the potential PI3K involvement in human SLE, whose study also revealed that the PI3K pathway was frequently activated in SLE patient peripheral blood mononuclear cells and T cells (∼70% of cases), more markedly in active disease phases. Our observations point to SLE as a novel phenotype of GOF mutation in <italic>PI3CKD</italic> gene. Phenotype of GOF mutation in <italic>PI3CKD</italic> gene can be the coexistence of immunodeficiency and autoimmunity.</p></sec><sec><title>Acknowledgments</title><p>The research team is thankful to our patient, Peng-Cheng Han, and his father, Hua Han.</p></sec><sec><title>Author contributions</title><p><bold>Conceptualization:</bold> Guo-Min Li, Li Sun.</p><p><bold>Data curation:</bold> Hai-Mei Liu, Wan-Zhen Guan, Hong Xu.</p><p><bold>Formal analysis:</bold> Bing-Bing Wu.</p><p><bold>Investigation:</bold> Hai-Mei Liu, Wan-Zhen Guan.</p><p><bold>Methodology:</bold> Guo-Min Li, Hong Xu, Bing-Bing Wu, Jia-Yan Feng, Li Sun.</p><p><bold>Project administration:</bold> Jia-Yan Feng.</p><p><bold>Writing – original draft:</bold> Guo-Min Li.</p><p><bold>Writing – review & editing:</bold> Hai-Mei Liu, Wan-Zhen Guan, Hong Xu, Li Sun.</p></sec></body><back><fn-group><fn fn-type="abbr"><p>Abbreviations: ANA = antinuclear antibodies, APDS = activated PI3Kδ syndrome, GOF = gain of function, PASLI = p110δ-activating mutation causing senescent T cells, lymphadenopathy, and immunodeficiency, PI3K = phosphoinositide 3-kinase, SLE = systemic lupus erythematosus.</p></fn><fn fn-type="COI-statement"><p>The authors have no conflicts of interest to disclose.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jean</surname><given-names>S</given-names></name><name><surname>Kiger</surname><given-names>AA</given-names></name></person-group><article-title>Classes of phosphoinositide 3-kinases at a glance</article-title>. <source>J Cell Sci</source><year>2014</year>;<volume>127</volume><issue>(Pt 5)</issue>:<elocation-id>923</elocation-id>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">24587488</pub-id></mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fruman</surname><given-names>DA</given-names></name><name><surname>Rommel</surname><given-names>C</given-names></name></person-group><article-title>PI3K and cancer: lessons, challenges and opportunities</article-title>. <source>Nat Rev Drug Discov</source><year>2014</year>;<volume>13</volume>:<elocation-id>140</elocation-id>–<lpage>56</lpage>.<pub-id pub-id-type="pmid">24481312</pub-id></mixed-citation></ref><ref id="R3"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname><given-names>H</given-names></name><name><surname>Mallya</surname><given-names>S</given-names></name><name><surname>Nguyen</surname><given-names>P</given-names></name><etal></etal></person-group><article-title>The selective phosphoinoside-3-kinase p110δ inhibitor IPI-3063 potently suppresses B cell survival, proliferation, and differentiation</article-title>. <source>Front Immunol</source><year>2017</year>;<volume>8</volume>:<elocation-id>747</elocation-id>.<pub-id pub-id-type="pmid">28713374</pub-id></mixed-citation></ref><ref id="R4"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deau</surname><given-names>MC</given-names></name><name><surname>Heurtier</surname><given-names>L</given-names></name><name><surname>Frange</surname><given-names>P</given-names></name><etal></etal></person-group><article-title>A human immunodeficiency caused by mutations in the PIK3R1 gene</article-title>. <source>J Clin Invest</source><year>2015</year>;<volume>125</volume>:<elocation-id>1764</elocation-id>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">25831445</pub-id></mixed-citation></ref><ref id="R5"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elgizouli</surname><given-names>M</given-names></name><name><surname>Lowe</surname><given-names>DM</given-names></name><name><surname>Speckmann</surname><given-names>C</given-names></name><etal></etal></person-group><article-title>Activating PI3Kδ mutations in a cohort of 669 patients with primary immunodeficiency</article-title>. <source>Clin Exp Immunol</source><year>2016</year>;<volume>183</volume>:<elocation-id>221</elocation-id>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">26437962</pub-id></mixed-citation></ref><ref id="R6"><label>[6]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coulter</surname><given-names>TI</given-names></name><name><surname>Chandra</surname><given-names>A</given-names></name><name><surname>Bacon</surname><given-names>CM</given-names></name><etal></etal></person-group><article-title>Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: a large patient cohort study</article-title>. <source>J Allergy Clin Immunol</source><year>2017</year>;<volume>139</volume>:<elocation-id>597</elocation-id>–<lpage>606</lpage>.<pub-id pub-id-type="pmid">27555459</pub-id></mixed-citation></ref><ref id="R7"><label>[7]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michalovich</surname><given-names>D</given-names></name><name><surname>Nejentsev</surname><given-names>S</given-names></name></person-group><article-title>Activated PI3 kinase delta syndrome: from genetics to therapy</article-title>. <source>Front Immunol</source><year>2018</year>;<volume>9</volume>:<elocation-id>369</elocation-id>.<pub-id pub-id-type="pmid">29535736</pub-id></mixed-citation></ref><ref id="R8"><label>[8]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picard</surname><given-names>C</given-names></name><name><surname>Bobby Gaspar</surname><given-names>H</given-names></name><name><surname>Al-Herz</surname><given-names>W</given-names></name><etal></etal></person-group><article-title>International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity</article-title>. <source>J Clin Immunol</source><year>2018</year>;<volume>38</volume>:<elocation-id>96</elocation-id>–<lpage>128</lpage>.<pub-id pub-id-type="pmid">29226302</pub-id></mixed-citation></ref><ref id="R9"><label>[9]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bousfha</surname><given-names>A</given-names></name><name><surname>Jeddane</surname><given-names>L</given-names></name><name><surname>Picard</surname><given-names>C</given-names></name><etal></etal></person-group><article-title>The 2017 IUIS phenotypic classification for primary immunodeficiencies</article-title>. <source>J Clin Immunol</source><year>2018</year>;<volume>38</volume>:<elocation-id>129</elocation-id>–<lpage>43</lpage>.<pub-id pub-id-type="pmid">29226301</pub-id></mixed-citation></ref><ref id="R10"><label>[10]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>X</given-names></name><name><surname>Miao</surname><given-names>Q</given-names></name><name><surname>Chang</surname><given-names>C</given-names></name><etal></etal></person-group><article-title>Common variable immunodeficiency and autoimmunity – an inconvenient truth</article-title>. <source>Autoimmun Rev</source><year>2014</year>;<volume>13</volume>:<elocation-id>858</elocation-id>–<lpage>64</lpage>.<pub-id pub-id-type="pmid">24747700</pub-id></mixed-citation></ref><ref id="R11"><label>[11]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahiminejad</surname><given-names>MS</given-names></name><name><surname>Mirmohammad Sadeghi</surname><given-names>M</given-names></name><name><surname>Mohammadinejad</surname><given-names>P</given-names></name><etal></etal></person-group><article-title>Evaluation of humoral immune function in patients with chronic idiopathic thrombocytopenic purpura</article-title>. <source>Iran J Allergy Asthma Immunol</source><year>2013</year>;<volume>12</volume>:<elocation-id>50</elocation-id>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">23454778</pub-id></mixed-citation></ref><ref id="R12"><label>[12]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abolhassani</surname><given-names>H</given-names></name><name><surname>Gharib</surname><given-names>B</given-names></name><name><surname>Shahinpour</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>Autoimmunity in patients with selective IgA deficiency</article-title>. <source>J Investig Allergol Clin Immunol</source><year>2015</year>;<volume>25</volume>:<elocation-id>112</elocation-id>–<lpage>9</lpage>.</mixed-citation></ref><ref id="R13"><label>[13]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunningham-Rundles</surname><given-names>C</given-names></name></person-group><article-title>Autoimmune manifestations in common variable immunodeficiency</article-title>. <source>J Clin Immunol</source><year>2008</year>;<volume>28</volume><issue>suppl 1</issue>:<elocation-id>S42</elocation-id>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">18322785</pub-id></mixed-citation></ref><ref id="R14"><label>[14]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abolhassani</surname><given-names>H</given-names></name><name><surname>Amirkashani</surname><given-names>D</given-names></name><name><surname>Parvaneh</surname><given-names>N</given-names></name><etal></etal></person-group><article-title>Autoimmune phenotype in patients with common variable immunodeficiency</article-title>. <source>J Investig Allergol Clin Immunol</source><year>2013</year>;<volume>23</volume>:<elocation-id>323</elocation-id>–<lpage>9</lpage>.</mixed-citation></ref><ref id="R15"><label>[15]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patiroglu</surname><given-names>T</given-names></name><name><surname>Gungor</surname><given-names>HE</given-names></name><name><surname>Unal</surname><given-names>E</given-names></name></person-group><article-title>Autoimmune diseases detected in children with primary immunodeficiency diseases: results from a reference centre at middle anatolia</article-title>. <source>Acta Microbiol Immunol Hung</source><year>2012</year>;<volume>59</volume>:<elocation-id>343</elocation-id>–<lpage>53</lpage>.<pub-id pub-id-type="pmid">22982638</pub-id></mixed-citation></ref><ref id="R16"><label>[16]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fried</surname><given-names>AJ</given-names></name><name><surname>Bonilla</surname><given-names>FA</given-names></name></person-group><article-title>Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections</article-title>. <source>Clin Microbiol Rev</source><year>2009</year>;<volume>22</volume>:<elocation-id>396</elocation-id>–<lpage>414</lpage>.<pub-id pub-id-type="pmid">19597006</pub-id></mixed-citation></ref><ref id="R17"><label>[17]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glocker</surname><given-names>E</given-names></name><name><surname>Grimbacher</surname><given-names>B</given-names></name></person-group><article-title>Inflammatory bowel disease: is it a primary immunodeficiency</article-title>. <source>Cell Mol Life Sci</source><year>2012</year>;<volume>69</volume>:<elocation-id>41</elocation-id>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">21997382</pub-id></mixed-citation></ref><ref id="R18"><label>[18]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavrador</surname><given-names>V</given-names></name><name><surname>Correia</surname><given-names>F</given-names></name><name><surname>Sampaio</surname><given-names>R</given-names></name><etal></etal></person-group><article-title>Membranoproliferative glomerulonephritis and x-linked agammaglobulinemia: an uncommon association</article-title>. <source>Case Rep Pediatr</source><year>2014</year>;<volume>2014</volume>:<elocation-id>480947</elocation-id>.<pub-id pub-id-type="pmid">24716070</pub-id></mixed-citation></ref><ref id="R19"><label>[19]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunningham-Rundles</surname><given-names>C</given-names></name></person-group><article-title>Hematologic complications of primary immune deficiencies</article-title>. <source>Blood Rev</source><year>2002</year>;<volume>16</volume>:<elocation-id>61</elocation-id>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">11913998</pub-id></mixed-citation></ref><ref id="R20"><label>[20]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angulo</surname><given-names>I</given-names></name><name><surname>Vadas</surname><given-names>O</given-names></name><name><surname>Garçon</surname><given-names>F</given-names></name><etal></etal></person-group><article-title>Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage</article-title>. <source>Science</source><year>2013</year>;<volume>342</volume>:<elocation-id>866</elocation-id>–<lpage>71</lpage>.<pub-id pub-id-type="pmid">24136356</pub-id></mixed-citation></ref><ref id="R21"><label>[21]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeda</surname><given-names>AJ</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Dornan</surname><given-names>GL</given-names></name><etal></etal></person-group><article-title>Novel PIK3CD mutations affecting N-terminal residues of p110δ cause activated PI3Kδ syndrome (APDS) in humans</article-title>. <source>J Allergy Clin Immunol</source><year>2017</year>;<volume>140</volume>:<elocation-id>1152</elocation-id>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">28414062</pub-id></mixed-citation></ref><ref id="R22"><label>[22]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arjunaraja</surname><given-names>S</given-names></name><name><surname>Snow</surname><given-names>AL</given-names></name></person-group><article-title>Gain-of-function mutations and immunodeficiency: at a loss for proper tuning of lymphocyte signaling</article-title>. <source>Curr Opin Allergy Clin Immunol</source><year>2015</year>;<volume>15</volume>:<elocation-id>533</elocation-id>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">26406182</pub-id></mixed-citation></ref><ref id="R23"><label>[23]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suárez-Fueyo</surname><given-names>A</given-names></name><name><surname>Barber</surname><given-names>DF</given-names></name><name><surname>Martínez-Ara</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Enhanced phosphoinositide 3-kinase δ activity is a frequent event in systemic lupus erythematosus that confers resistance to activation-induced T cell death</article-title>. <source>J Immunol</source><year>2011</year>;<volume>187</volume>:<elocation-id>2376</elocation-id>–<lpage>85</lpage>.<pub-id pub-id-type="pmid">21810603</pub-id></mixed-citation></ref></ref-list></back></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000318 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000318 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:6504300
|texte= A mutation in PIK3CD gene causing pediatric systemic lupus erythematosus
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:31045771" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a ChloroquineV1
| This area was generated with Dilib version V0.6.33. |  |